Table 3 Mortality in ESRD patients who received CABG
Variable | Event (%) | Death | Proportion | aHR (95% CI) | P value |
|---|---|---|---|---|---|
Total | 48 | 16 | 0.33 | ||
Hypertension | 34 (70.83) | 12 | 0.35 | 1.31 (0.42–4.06) | .644 |
Diabetes | 32 (66.67) | 13 | 0.41 | 2.32 (0.66–8.17) | .189 |
Myocardial infarction | 14 (29.17) | 8 | 0.57 | 2.83 (1.06–7.58) | .038 |
Stroke | 15 (31.25) | 7 | 0.47 | 2.31 (0.85–6.26) | .099 |
Congestive heart failure | 28 (58.33) | 9 | 0.32 | 0.87 (0.32–2.33) | .780 |
Peripheral arterial disease | 10 (20.83) | 4 | 0.40 | 1.46 (0.47–4.54) | .511 |
COPD | 8 (16.67) | 5 | 0.63 | 2.43 (0.84–7.02) | .100 |